Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering

Biomaterials

Volumn 34, Issue 28, 2013, Pages 6572-6579

  Moshaverinia, Alireza ^a   Ansari, Sahar ^a   Chen, Chider ^a   Xu, Xingtian ^a   Akiyama, Kentaro ^a   Snead, Malcolm L ^a   Zadeh, Homayoun H ^a   Shi, Songtao ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alginate hydrogel; Anti BMP2 monoclonal antibodies; Cells encapsulation; Mesenchymal stem cell mediated bone regeneration

Indexed keywords

ALGINATE HYDROGELS; BONE REGENERATION; BONE TISSUE ENGINEERING; HISTOLOGIC ANALYSIS; HUMAN BONE MARROW MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; MONOCLONAL ANTIBODIES (MABS); OSTEOGENIC DIFFERENTIATION;

BONE; CELL CULTURE; DEFECTS; LIGANDS; MICROSPHERES; MONOCLONAL ANTIBODIES; REPAIR; STEM CELLS; SURFACE PLASMON RESONANCE; TISSUE ENGINEERING;

ALGINATE;

ALGINIC ACID; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 2 MONOCLONAL ANTIBODY; MICROSPHERE; MONOCLONAL ANTIBODY; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; BONE TISSUE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; TISSUE ENGINEERING;

ADULT; ALGINATES; ANIMALS; ANTIBODIES, MONOCLONAL; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMAL CELLS; MICE; MICROSPHERES; TISSUE ENGINEERING; YOUNG ADULT;

MURINAE; MUS;

EID: 84879464132     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.048     Document Type: Article

References (40)

1. Sachlos E., Czernuszka J.T. Making tissue engineering scaffolds work. Review on the application of solid freeform fabrication technology to the production of tissue engineering scaffold. Eur Cell Mater 2003, 5:29-40.
2. Porter J.R., Ruckh T.T., Popat K.C. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009, 25:1539-1560.
3. Monaco E., Bionaz M., Hollister S.J., Wheeler M.B. Strategies for regeneration of the bone using porcine adult adipose-derived mesenchymal stem cells. Theriogenology 2011, 75:1381-1399.
4. Betz V.M., Betz O.B., Harris M.B., Vrahas M.S., Evans C.H. Bone tissue engineering and repair by gene therapy. Front Biosci 2008, 13:833-841.
5. Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., Davino N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996, 329:300-309.
6. Kretlow J.D., Young S., Klouda L., Wong M., Mikos A.G. Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater 2009, 21:3368-3379.
7. Hill E., Boontheekul T., Mooney D.J. Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng Part A 2006, 12:1295-1302.
8. García-Gómez I., Elvira G., Zapata A.G., Lamana M.L., Ramírez M., Castro J.G., et al. Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther 2010, 10:1453-1468.
9. Tasso R., Fais F., Reverberi D., Tortelli F., Cancedda R. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 2010, 31:2121-2129.
10. Chung I.H., Yamaza T., Zhao H., Choung P.H., Shi S., Chai Y. Stem cell property of post migratory cranial crest cells and their utility in alveolar bone regeneration and tooth development. Stem Cells 2009, 27:866-877.
11. Bueno E.M., Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 2009, 5:685-697.
12. Liu Y., Wang L., Kikuiri T., Akiyama K., Chen C., Xu X., et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med 2011, 17:1594-1601.
13. Liu J., Sato C., Cerletti M., Wagers A. Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr Top Dev Biol 2010, 92:367-409.
14. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005, 308:1472-1477.
15. Czyz J., Wobus A.M. Embryonic stem cell differentiation: the role of extracellular factors. Differentiation 2001, 68:167-174.
16. Chin M., Ng T., Tom W., Carstens M. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. JCraniofac Surg 2005, 16:778-790.
17. Khan S., Lane J. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin Biol Ther 2004, 4:741-753.
18. Wikesjo U.M., Polimeni G., Qahash M. Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives. Clin Implant Dent Relat Res 2005, 7:112-129.
19. Zhu W., Rawlins B.A., Boachie-Adjei O., Myers E.R., Arimizu J., Choi E., et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. JBone Miner Res 2004, 19:2021-2032.
20. Freire M.O., You H.K., Kook J.K., Choi J.H., Zadeh H.H. Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies. Tissue Eng Part A 2011, 17:2911-2921.
21. Freire M.O., Kim H.K., Kook J.K., Nguyen A., Zadeh H.H. Antibody-mediated osseous regeneration: the early events in the healing response. Tissue Eng Part A 2013, 19:1165-1174.
22. Shi S., Gronthos S., Chen S., Reddi A., Counter C.M., Robey P.G., et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 2002, 20:587-591.
23. Moshaverinia A., Chen C., Akiyama K., Ansari S., Xu X., Chee W.W., et al. Alginate hydrogel as a promising scaffold for dental-derived stem cells: an invitro study. JMater Sci Mater Med 2012, 23:3041-3051.
24. Moshaverinia A, Chen C, Akiyama K, Xu X, Chee WW, Schricker SR, et al. Encapsulated dental-derived stem cells in an injectable and biodegradable scaffold for applications in bone tissue engineering. J Biomed Mater Res Part A, in press.
25. Guo X., Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009, 19:71-88.
26. Zhang Y.E. Non-Smad pathways in TGF-signaling. Cell Res 2009, 19:128-139.
27. Ishikawa H., Kitoh H., Sugiura F., Ishiguro N. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages. Acta Orthop 2007, 78:285-296.
28. Oldham J., Lu L., Zhu X., Porter B., Hefferan T., Larson D., et al. Biological activity of rhBMP-2 released from PLGA microspheres. JBiomech Eng 2000, 122:289.
29. Chen D., Zhao M., Mundy G. Bone morphogenetic proteins. Growth Factors 2004, 22:233.
30. Knippenberg M., Helder M.N., Zandieh D.B., Wuisman P.I., Klein-Nulend J. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem Biophys Res Commun 2006, 342:902-908.
31. Liu D.D., Zhang J.C., Zhang Q., Wang S.X., Yang M.S. TGF-β/BMP signaling pathway is involved in cerium-promoted osteogenic differentiation of mesenchymal stem cells. JCell Biochem 2013, 114:1105-1114.
32. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
33. Valamehr B., Jonas S.J., Polleux J., Qiao R., Guo S., Gschweng E.H., et al. Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies. Proc Natl Acad Sci U S A 2008, 105:14459-14464.
34. Sapir Y., Kryukov O., Cohen S. Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 2011, 7:1838-1847.
35. Evangelista M.B., Hsiong S.X., Fernandes R., Sampaio P., Kong H., Barrias C.C., et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 2007, 28:3644-3655.
36. Cantu D.A., Hematti P., Kao W.J. Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype. Stem Cell Transl Med 2012, 1:740-749.
37. Wang W., Ma N., Kratz K., Xu X., Li Z., Roch T., et al. The influence of polymer scaffolds on cellular behaviour of bone marrow derived human mesenchymal stem cells. Clin Hemorheol Microcirc 2012, 52:357-373.
38. Alsberg A., Anderson K.W., Albeiruti A., Franceschi R.T., Mooney D.J. Cell-interactive alginate hydrogels for bone tissue engineering. JDent Res 2001, 80:2025-2029.
39. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20:45-51.
40. Smidsrod O., Skjakbraek G. Alginate as immobilization matrix for cells. Trends Biotechnol 1990, 8:71-78.